this Member support's the conference report for H.R. 4461, the FY2001 Agriculture Appropriations bill. In particular, this Member commends the distinguished gentleman from New Mexico (Mr. Skeen), Chairman of the Agriculture Appropriations Subcommittee and the distinguished gentlelady from Ohio (Ms. Kaptur), Ranking Member of the Subcommittee for their hard work on this critically important bill. This conference report contains $3.5 billion in critical emergency disaster relief for agriculture producers. This, of course, is in addition to the $7.1 billion in economic assistance for agriculture producers including $5.5 billion in higher Agricultural Market Transition Act (AMTA) payments as part of the crop insurance reform legislation signed into law earlier this year on June 22, 2000. The emergency funds in the conference report we are considering today are particularly important to Nebraska farmers, because drought conditions in the Great Plains have substantially lowered production at a time when we have low commodity prices.
Doug Bereuter: “this Member support's the conference report for H.R. 4461, the FY2001 Agriculture Appropriations bill. In particular…”
Editor's note · Context
Discussing support for the FY2001 Agriculture Appropriations bill and its impact on farmers.
Share
More from Doug Bereuter
Several weeks ago, this House for the first time in 6 years spoke unanimously and decisively on the current situation involving Cyprus. On March 27, this body voted 422-0 to express our disappointment that a United Nations-backed…
This bill will give FEMA the needed tools to reduce the number of repetitive loss properties which cost the NFIP about $200 million annually. These properties, while comprising approximately 1 percent of the currently insured properties…
I have fought this process for over a year. The first letters I received from the Department of Interior were, shall I say, nonresponsive and also condescending. There are only three such centers in the United States. We are dealing with…
this amendment requires the Agency for Healthcare Research and Quality to spend $12 million for the conduct of research on the comparative effectiveness, cost effectiveness, and safety of drugs, biological products and devices under their…